{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:07:26Z","timestamp":1759774046735,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejim.2024.06.017","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T03:24:31Z","timestamp":1718940271000},"page":"149-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Direct oral anticoagulants or vitamin K antagonists in adult patients with congenital heart disease?"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-5713","authenticated-orcid":false,"given":"Paschalis","family":"Karakasis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Theofilis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Patoulias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Fragakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2024.06.017_bib0001","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/CIRCULATIONAHA.109.866319","article-title":"Atrial arrhythmias in adults with congenital heart disease","volume":"120","author":"Bouchardy","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.06.017_bib0002","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC Guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.06.017_bib0003","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s10557-022-07357-5","article-title":"Non-VKA oral anticoagulants in adult congenital heart disease: a single-center study","volume":"37","author":"Br\u00e1s","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ejim.2024.06.017_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131993","article-title":"Use of apixaban in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study","author":"Kartas","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2024.06.017_bib0005","article-title":"Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe","volume":"6","author":"Yang","year":"2019","journal-title":"Open Hear"},{"key":"10.1016\/j.ejim.2024.06.017_bib0006","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10557-021-07298-5","article-title":"A multisite retrospective review of direct oral anticoagulants compared to warfarin in adult fontan patients","volume":"37","author":"Kazerouninia","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ejim.2024.06.017_bib0007","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejim.2024.06.017_bib0008","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1093\/eurheartj\/ehaa844","article-title":"Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients","volume":"41","author":"Freisinger","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.06.017_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061794","article-title":"Non-Vitamin K oral anticoagulants in adults with congenital heart disease: a systematic review","volume":"9","author":"Stalikas","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2024.06.017_bib0010","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jacc.2018.08.1028","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524002693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524002693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T01:36:36Z","timestamp":1730597796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524002693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":10,"alternative-id":["S0953620524002693"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.06.017","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulants or vitamin K antagonists in adult patients with congenital heart disease?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}